Showing results (41-50 of 123) with videos related to
Sort By:
Pageof 13
Annals of Surgical Oncology|May 23, 2018
CA19-9 on Postoperative Surveillance in Pancreatic Ductal Adenocarcinoma: Predicting Recurrence and Changing Prognosis over TimeCaroline J Rieser, Mazen Zenati, Ahmad Hamad, et al.Annals of Surgical Oncology|November 30, 2016
Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes?Filip Bednar, Mazen S Zenati, Jennifer Steve, et al.Journal of Surgical Oncology|December 17, 2019
Impact of adjuvant chemotherapy regimen on survival outcomes in immunohistochemical subtypes of ampullary carcinomaAmr I Al Abbas, Virginia Falvello, Mazen Zenati, et al.Blood|June 21, 2007
Functional conservation of erythropoietin signaling in zebrafishNoëlle Paffett-Lugassy, Nelson Hsia, Paula G Fraenkel, et al.Journal of Gastrointestinal Cancer|September 3, 2010
Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive marginsJean-Claude M Rwigema, Dwight E Heron, Simul D Parikh, et al.Advances in Radiation Oncology|April 24, 2019
Initial Results of a Prospective Study of Adjuvant Pancreatic Stereotactic Body Radiation Therapy for Close or Positive MarginsMark E Bernard, Philip A Sutera, Nicholas A Iarrobino, et al.Annals of Surgical Oncology|July 7, 2017
Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize SurvivalIrene Epelboym, Mazen S Zenati, Ahmad Hamad, et al.Frontiers in Oncology|November 30, 2017
One- vs. Three-Fraction Pancreatic Stereotactic Body Radiation Therapy for Pancreatic Carcinoma: Single Institution Retrospective ReviewPhilip Anthony Sutera, Mark E Bernard, Beant S Gill, et al.Annals of Surgical Oncology|January 2, 2021
Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant ChemotherapyMohamed Abdelgadir Adam, Ibrahim Nassour, Richard Hoehn, et al.Practical Radiation Oncology|January 3, 2018
Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinomaKimmen Quan, Philip Sutera, Karen Xu, et al.Pageof 13